Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 30

1.

Cardiovascular diseases, diabetes mellitus, and cancer in the occupied Palestinian territory.

Husseini A, Abu-Rmeileh NM, Mikki N, Ramahi TM, Ghosh HA, Barghuthi N, Khalili M, Bjertness E, Holmboe-Ottesen G, Jervell J.

Lancet. 2009 Mar 21;373(9668):1041-9. doi: 10.1016/S0140-6736(09)60109-4. Epub 2009 Mar 4. Erratum in: Lancet. 2009 May 23;373(9677):1764.

PMID:
19268350
2.

[Non-communicable chronic diseases in Brazil: from risk factors to social impact].

Lessa I, Mendonça GA, Teixeira MT.

Bol Oficina Sanit Panam. 1996 May;120(5):389-413. Review. Portuguese.

PMID:
8924219
3.

Noncommunicable diseases among the Bahraini population: a review.

Hamadeh RR.

East Mediterr Health J. 2000 Sep-Nov;6(5-6):1091-7. Review.

PMID:
12197332
4.

World Heart Day 2002: the international burden of cardiovascular disease: responding to the emerging global epidemic.

Bonow RO, Smaha LA, Smith SC Jr, Mensah GA, Lenfant C.

Circulation. 2002 Sep 24;106(13):1602-5. Review. No abstract available.

5.

Diabetes mellitus in Bahrain: an overview.

Musaiger AO.

Diabet Med. 1992 Jul;9(6):574-8. Review.

PMID:
1643809
6.

The public health impact of obesity.

Visscher TL, Seidell JC.

Annu Rev Public Health. 2001;22:355-75. Review.

PMID:
11274526
7.

The Burden of Cardiovascular Disease in Low- and Middle-Income Countries: Epidemiology and Management.

Bowry AD, Lewey J, Dugani SB, Choudhry NK.

Can J Cardiol. 2015 Sep;31(9):1151-9. doi: 10.1016/j.cjca.2015.06.028. Epub 2015 Jul 3. Review.

PMID:
26321437
8.

[Cardiovascular risk and cardiometabolic risk: an epidemiological evaluation].

Vanuzzo D, Pilotto L, Mirolo R, Pirelli S.

G Ital Cardiol (Rome). 2008 Apr;9(4 Suppl 1):6S-17S. Review. Italian.

PMID:
18773746
9.

Evidence-based disease management: its role in cardiovascular risk reduction.

Fanning EL.

Dis Manag. 2004 Fall;7 Suppl 1:S7-10. Review.

PMID:
15669573
10.

Medical morbidity and mortality in schizophrenia: guidelines for psychiatrists.

Goff DC, Cather C, Evins AE, Henderson DC, Freudenreich O, Copeland PM, Bierer M, Duckworth K, Sacks FM.

J Clin Psychiatry. 2005 Feb;66(2):183-94; quiz 147, 273-4. Review.

PMID:
15705003
11.

Reducing the global burden of cardiovascular disease: the role of risk factors.

Levenson JW, Skerrett PJ, Gaziano JM.

Prev Cardiol. 2002 Fall;5(4):188-99. Review.

12.

Cardiovascular prevention: components, levels, early origins, and metrics.

Kones R, Rumana U.

Hosp Pract (1995). 2014 Aug;42(3):84-95. doi: 10.3810/hp.2014.08.1121. Review.

PMID:
25255410
13.

Disease and injury in California with projections to the year 2007. Implications for medical education.

Ragland DR, Buffler PA, Reingold AL, Syme SL, Buffler ML.

West J Med. 1998 May;168(5):378-99. Review.

14.

Stroke in Arab countries: a systematic literature review.

Benamer HT, Grosset D.

J Neurol Sci. 2009 Sep 15;284(1-2):18-23. doi: 10.1016/j.jns.2009.04.029. Epub 2009 May 9. Review.

PMID:
19428027
15.

Shared Risk Factors in Cardiovascular Disease and Cancer.

Koene RJ, Prizment AE, Blaes A, Konety SH.

Circulation. 2016 Mar 15;133(11):1104-14. doi: 10.1161/CIRCULATIONAHA.115.020406. Review.

16.

CVD and obesity in transitional Syria: a perspective from the Middle East.

Barakat H, Barakat H, Baaj MK.

Vasc Health Risk Manag. 2012;8:145-50. doi: 10.2147/VHRM.S28691. Epub 2012 Mar 6. Review.

17.

Novel therapeutic concepts: the epidemic of cardiovascular disease in the developing world: global implications.

Gersh BJ, Sliwa K, Mayosi BM, Yusuf S.

Eur Heart J. 2010 Mar;31(6):642-8. doi: 10.1093/eurheartj/ehq030. Epub 2010 Feb 22. Review.

PMID:
20176800
18.

Costs, benefits, and effectiveness of interventions for the prevention, treatment, and control of cardiovascular diseases and diabetes in Africa.

Mendis S, Chestnov O.

Prog Cardiovasc Dis. 2013 Nov-Dec;56(3):314-21. doi: 10.1016/j.pcad.2013.09.001. Review.

PMID:
24267438
19.

[Physical activity in basic and primary prevention of cardiovascular disease].

Sobieszczańska M, Kałka D, Pilecki W, Adamus J.

Pol Merkur Lekarski. 2009 Jun;26(156):659-64. Review. Polish.

PMID:
19711738
20.

[Type 2 diabetes mellitus and cardiovascular risk factors: is comprehensive treatment required?].

Nadal JF, Gutiérrez PC.

Med Clin (Barc). 2013 Sep;141 Suppl 2:7-13. doi: 10.1016/S0025-7753(13)70057-5. Review. Spanish.

PMID:
24444518

Supplemental Content

Support Center